We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Comparison of parturient -- controlled remifentanil with epidural bupivacain and sufentanil for labour analgesia: Randomised controlled trial.
- Authors
Stourac, Petr; Suchomelova, Hana; Stodulkova, Marta; Huser, Martin; Krikava, Ivo; Janku, Petr; Haklova, Olga; Hakl, Lubomir; Stoudek, Roman; Gal, Roman; Sevcik, Pavel
- Abstract
Introduction. Epidural analgesia (EA) has significant contraindications including coagulation disorders and parturient refusal. One alternative is intravenous self-administered analgesia using the ultra short-acting opioid remifentanil (rPCA). We compared the efficiency and safety of standard epidural analgesia with parturient-controlled intravenous analgesia using remifentanil as well as personal satisfaction. Materials and Methods. We enrolled twelve ASA I classified women with singleton pregnancy who delivered vaginally in the period 3/2010-5/2010 and who received rPCA (n=12) in standard analgesic protocol: 20 μg boluses using PCA pump with a lockout interval of 3 min. The control group consisted of 12 pregnant women who received EA (n=12): 0.125% bupivacaine with sufentanil 0.5 μg/mL in top-up boluses every hour until delivery. Data were acquired from standard Acute Pain Service (APS) form and patient medical records (demographic, labour course parameters), Visual Analogue Scale (VAS), Bromage Scale (BS) and adverse effects of analgesia. Results. There were no demographic or labour course parameter differences between groups (P>0.05).The differences in VAS decrease (P=0.056) and parturient satisfaction (P=0.24) during the whole analgesia administration were statistically insignificant. The main limitation of the study was small sample and enrolment of healthy singleton pregnant women only. Conclusion. Remifentanil use in obstetric analgesia is a viable alternative to EA, especially in cases of EA contraindications and parturient disapproval.
- Subjects
MILK fever in animals; REMIFENTANIL; SUFENTANIL; RANDOMIZED controlled trials; DRUG efficacy; MEDICATION safety; PREGNANCY complications
- Publication
Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, 2014, Vol 158, Issue 2, p227
- ISSN
1213-8118
- Publication type
Article
- DOI
10.5507/bp.2012.073